Select Medical (SEM)
(Delayed Data from NYSE)
$34.09 USD
-0.17 (-0.50%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $34.08 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.09 USD
-0.17 (-0.50%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $34.08 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Zacks News
5 Low Price-to-Book Stocks to Buy in November
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), Centene (CNC), Paysafe Limited (PSFE) and HF Sinclair Corporation (DINO) are some such stocks.
Give Your Investments a Boost With These 4 Low P/CF Stocks
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), Hibbett (HIBB), PVH Corp. (PVH) and Centene Corporation (CNC) boast low P/CF ratios.
Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit
by Zacks Equity Research
Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.
Universal Health (UHS) Q3 Earnings Beat on Adjusted Patient Days
by Zacks Equity Research
Universal Health (UHS) has a leftover repurchase capacity of around $580 million as of Sep 30, 2023.
Select Medical (SEM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Select Medical (SEM) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised
by Zacks Equity Research
Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.
Centene (CNC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 26.58% and 5.13%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Select Medical (SEM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for October 19th
by Zacks Equity Research
BBC, HSBC and SEM made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 19, 2023.
Best Income Stocks to Buy for October 19th
by Zacks Equity Research
HSBC, FFBC and SEM made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 19, 2023.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Add to Your Kitty in October
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), KB Home (KBH), Paysafe Limited (PSFE) and HF Sinclair Corporation (DINO) are some such stocks.
Zacks.com featured highlights Select Medical, Marathon Oil, PVH and KB Home
by Zacks Equity Research
Select Medical, Marathon Oil, PVH and KB Home have been highlighted in this Screen of The Week article.
Here's Why You Should Hold Centene (CNC) in Your Portfolio
by Zacks Equity Research
Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
Unlock the Value of Your Portfolio With 4 Low P/CF Stocks
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. Select Medical Holdings (SEM), Marathon Oil (MRO), PVH Corp. (PVH) and KB Home (KBH) boast low P/CF ratios.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.63% and 1.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Best Growth Stocks to Buy for October 13th
by Zacks Equity Research
PANW, SEM and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2023.
Best Income Stocks to Buy October 13th
by Zacks Equity Research
FANG, SEM and KUBTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 13, 2023.
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
by Zacks Equity Research
Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.
Cigna's (CI) Evernorth Launches Value-Based Care Program
by Zacks Equity Research
Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.
Brookdale's (BKD) September 2023 Occupancy Volumes Increase
by Zacks Equity Research
Brookdale (BKD) has seen a continuous streak of 23 months of year-over-year increases in the weighted average occupancy level.
Best Growth Stocks to Buy for October 10th
by Zacks Equity Research
SEM, JELD and URBN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 10, 2023.
Ensign (ENSG) Buys Providence Place Nursing Facility in Kansas
by Zacks Equity Research
The Providence Place deal increases Ensign's (ENSG) portfolio to encompass 296 healthcare operations, spanning 13 states.
UnitedHealth (UNH) Arm Optum Partners With ProHealth Care
by Zacks Equity Research
Per the deal, more than 800 employees of ProHealth Care are likely to shift to UnitedHealth's (UNH) Optum business.